These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18025624)

  • 21. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
    Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taskintuna I; Firat E
    Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
    Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N
    Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behçet's disease and deafness. Remission under methylprednisolone pulse treatment].
    Wechsler B; Farge D; Piette JC; Lamas G; Chapelon C; Godeau P
    Rev Med Interne; 1988; 9(1):67-8. PubMed ID: 3368662
    [No Abstract]   [Full Text] [Related]  

  • 26. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
    Amer R; Alsughayyar W; Almeida D
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
    Taban M; Lowder CY; Kaiser PK
    Retina; 2008 Oct; 28(9):1280-8. PubMed ID: 18628725
    [No Abstract]   [Full Text] [Related]  

  • 28. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
    Kötter I; Zierhut M; Eckstein A; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Kanz L; Stübiger N
    Adv Exp Med Biol; 2003; 528():521-3. PubMed ID: 12918755
    [No Abstract]   [Full Text] [Related]  

  • 29. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
    Giansanti F; Barbera ML; Virgili G; Pieri B; Emmi L; Menchini U
    Eur J Ophthalmol; 2004; 14(5):445-8. PubMed ID: 15506610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case study of neuro-psycho-Behçet's syndrome presenting with psychotic attack.
    Deniz O; Cayköylü A; Vural G; Albayrak Y; Temel S; Aydin I; Kuloğlu M
    Clin Neurol Neurosurg; 2009 Dec; 111(10):877-9. PubMed ID: 19647932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cataracts, chronic uveitis, and retinal vasculitis in Behçet's disease.
    Zadnik K
    Am J Optom Physiol Opt; 1987 Jan; 64(1):72-5. PubMed ID: 3826281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of acute constrictive pericarditis associated with Behçet's disease.
    Tahir T
    Int J Rheum Dis; 2011 Oct; 14(4):e51-3. PubMed ID: 22004240
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uveitis in Behçet's disease.
    Nussenblatt RB
    Int Rev Immunol; 1997; 14(1):67-79. PubMed ID: 9203027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataract extraction in Behçet's disease.
    Ciftci OU; Ozdemir O
    Acta Ophthalmol Scand; 1996 Feb; 74(1):74-6. PubMed ID: 8689487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results.
    Coşkun E; Celemler P; Kimyon G; Öner V; Kisacik B; Erbagci I; Onat AM
    Ocul Immunol Inflamm; 2015; 23(6):437-43. PubMed ID: 26470764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
    Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B
    Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.